WHITE PAPERS:

How LabVantage supports 21 CFR Part 11 & Annex 11

Helping Customers Comply with these Requirements

For customers in regulated industries, compliance with the U.S. FDA’s 21 CFR Part 11 and the EU’s EudraLex issued Annex 11 is no small task. This white paper describes how LabVantage helps customers comply with regulations on electronic records and signatures, and computerized systems producing medicinal products for human or veterinary use. The paper also discusses LabVantage’s compliance with guidance on temporary data.

Please fill out the form to download our white paper:

HOW LABVANTAGE SUPPORTS 21 CFR PART 11 & ANNEX 11